Ras-related protein Rab24 plays a predictive role in hepatocellular carcinoma and enhanced tumor proliferation

Figure 4 Stratification survival analyses of hepatocellular carcinoma patients. A-C: Hepatocellular carcinoma (HCC) patients with tumor-node-metastasis stage I (A), stage II (B), or stage III (C) were independently analyzed to evaluate the prognostic effect of Rab24 level; D-F: Meanwhile, patients with negative-hepatitis B virus (HBV) infection history (D) or positive-HBV history (E) were also stratified, further revealing the unfavorable role of Rab24 in HCC patients (F). Patients who received chemotherapy using Sorafenib without surgical treatment were also analyzed to test the prognostic effect of Rab24. Data was analyzed by log-rank test using Kaplan-Meier method. HBV: Hepatitis B virus; TNM: Tumor-node-metastasis.